Initial report of Panstrongylus rufotuberculatus (Champion, 1899) Triatominae (Hemiptera: Reduviidae) in Roraima, western Amazon state, Brazil.

BACKGROUND: This study is the first report of the species Panstrongylus rufotuberculatus in Roraima, a state in northern Brazil. METHODS: We collected specimens from a residence in the municipality of Rorainópolis. RESULTS: Our findings confirmed the occurrence of this species in Roraima, increasing the number of registered species from six to seven. CONCLUSIONS: Future studies are required to further investigate and expand our knowledge of the occurrence of this species and its epidemiological importance for this state.

Initial report of Panstrongylus rufotuberculatus (Champion, 1899) Triatominae (Hemiptera: Reduviidae) in Roraima, western Amazon state, Brazil

ABSTRACT Background: This study is the first report of the species Panstrongylus rufotuberculatus in Roraima, a state in northern Brazil. Methods: We collected specimens from a residence in the municipality of Rorainópolis. Results: Our findings confirmed the occurrence of this species in Roraima, increasing the number of registered species from six to seven. Conclusions: Future studies are required to further investigate and expand our knowledge of the occurrence of this species and its epidemiological importance for this state.

Implantable cardioverter-defibrillator prevents sudden death in patients with Chagas cardiomyopathy in the Brazilian Amazon.

Chagas disease (CD), with approximately 10,000 deaths annually, has become a worldwide health problem. Approximately 35% of cases may show cardiac manifestations such as arrhythmias and/or conduction disorders, heart failure, thromboembolic accidents, and sudden death. The Amazon region has long been considered a non-endemic area for CD; however, in the last decades, with an increase in the number of acute and chronic cases, disease evolution has received greater attention. Here, we report the successful implementation of a cardioverter-defibrillator for the prevention of sudden death in a patient with autochthonous Chagas cardiomyopathy in the Brazilian Amazon.

Implantable cardioverter-defibrillator prevents sudden death in patients with Chagas cardiomyopathy in the Brazilian Amazon

Abstract Chagas disease (CD), with approximately 10,000 deaths annually, has become a worldwide health problem. Approximately 35% of cases may show cardiac manifestations such as arrhythmias and/or conduction disorders, heart failure, thromboembolic accidents, and sudden death. The Amazon region has long been considered a non-endemic area for CD; however, in the last decades, with an increase in the number of acute and chronic cases, disease evolution has received greater attention. Here, we report the successful implementation of a cardioverter-defibrillator for the prevention of sudden death in a patient with autochthonous Chagas cardiomyopathy in the Brazilian Amazon.